Table: begin end state 1 26 cytoplasmic 27 44 transmembrane 45 49 non-cytoplasmic 50 72 transmembrane 73 103 cytoplasmic 104 126 transmembrane 127 131 non-cytoplasmic 132 152 transmembrane 153 161 cytoplasmic 162 186 transmembrane 187 211 non-cytoplasmic 212 234 transmembrane 235 250 cytoplasmic 251 272 transmembrane 273 284 non-cytoplasmic 285 308 transmembrane 309 343 cytoplasmic 344 364 transmembrane 365 369 non-cytoplasmic 370 396 transmembrane 397 415 cytoplasmic 416 434 transmembrane 435 439 non-cytoplasmic 440 458 transmembrane 459 463 cytoplasmic
Input: >WP_084934657.1 NCBI__GCF_002095475.1:WP_084934657.1 MVDQSKEALIEAEQPEKLRRNLHNRHIQLIAIGGAIGTGLFMGSGKTISLAGPSIIFVYM IIGFMLFFVMRAMGELLLSNLEYKSFSDFAADLLGPWAGYFTGWTYWFCWVVTGIADVVA ISAYFQLWFPGFSIWMSALLCIFAFLALNIATVKLFGEMEFWFAIIKIVAIVALIITGIV LVSMHYPSPNGTTASLSNIWDHGGMFPKGLSGFFAGFQIAVFAFVGIELVGTAAAETKDP HKVLPRAINAIPVRIIMFYVLALLVIMAVTPWNQVLPNRSPFVEMFVLIGLPAAASIVNF VVLTSAASSANSGIFSTSRMLFGLAELGVAHKAFGRLSARAVPTTGLFFSCLCLLVGVAL IYLIPDVMTVFTMVTTVSAILFMFVWTIILCSYLAYRKQHPQRHAASKFKMPLGKFMCWV CMAFFAFVLVLLTLQEDTRQALMVTPLWFVILTLGWLLRRRKA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server